Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1978 1
1983 2
1991 2
1993 2
1994 1
1995 1
1996 1
1998 1
2000 1
2001 1
2002 1
2004 1
2005 1
2006 1
2007 1
2008 2
2009 3
2010 2
2011 3
2012 3
2013 3
2014 3
2015 4
2016 4
2017 6
2019 5
2020 5
2021 2
2022 3
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Chemotherapeutic Drug - Induced Nephropathy"
Page 1
Medication-Induced Interstitial Nephritis in the 21st Century.
Nast CC. Nast CC. Adv Chronic Kidney Dis. 2017 Mar;24(2):72-79. doi: 10.1053/j.ackd.2016.11.016. Adv Chronic Kidney Dis. 2017. PMID: 28284382 Review.
Drug-induced acute interstitial nephritis (DI-AIN) occurs in 0.5%-3% of all kidney biopsies and in 5%-27% of biopsies performed for acute kidney injury. ...As rapid drug discontinuation may improve prognosis, the possibility of DI-AIN sho …
Drug-induced acute interstitial nephritis (DI-AIN) occurs in 0.5%-3% of all kidney biopsies and in 5%-27% of biopsies p …
Drug-induced gene expression profile changes in relation to intestinal toxicity: State-of-the-art and new approaches.
Rodrigues D, Souza T, Jennen DGJ, Lemmens L, Kleinjans JCS, de Kok TM. Rodrigues D, et al. Cancer Treat Rev. 2019 Jul;77:57-66. doi: 10.1016/j.ctrv.2019.06.004. Epub 2019 Jun 27. Cancer Treat Rev. 2019. PMID: 31279169 Free article. Review.
In comparison to the other organs, less progress has been made on human-relevant prediction of drug-induced intestinal toxicity, evidencing current large data gaps. ...Chemotherapeutics are regarded as inducers of acute intestinal toxicity where …
In comparison to the other organs, less progress has been made on human-relevant prediction of drug-induced intestinal …
Onco-nephrology: renal toxicities of chemotherapeutic agents.
Perazella MA. Perazella MA. Clin J Am Soc Nephrol. 2012 Oct;7(10):1713-21. doi: 10.2215/CJN.02780312. Epub 2012 Aug 9. Clin J Am Soc Nephrol. 2012. PMID: 22879440 Review.
Despite dramatic improvements in patient survival and drug tolerability, nephrotoxicity remains an important complication of chemotherapy. Adverse renal effects occur because of innate drug toxicity and a number of patient- and drug-related factors. ...
Despite dramatic improvements in patient survival and drug tolerability, nephrotoxicity remains an important complication of chemothe …
Nephrotoxicity of semustine.
Weiss RB, Posada JG Jr, Kramer RA, Boyd MR. Weiss RB, et al. Cancer Treat Rep. 1983 Dec;67(12):1105-12. Cancer Treat Rep. 1983. PMID: 6360348 Review.
Semustine is an investigational cancer chemotherapeutic agent in widespread use. This agent has now been documented to produce nephrotoxicity and renal failure with long-term administration. ...Using these 35 cases as a data base, we have analyzed the incidence, dose and t …
Semustine is an investigational cancer chemotherapeutic agent in widespread use. This agent has now been documented to produce nephro …
The link between kidney disease and cancer: complications and treatment.
Malyszko J, Tesarova P, Capasso G, Capasso A. Malyszko J, et al. Lancet. 2020 Jul 25;396(10246):277-287. doi: 10.1016/S0140-6736(20)30540-7. Lancet. 2020. PMID: 32711803 Review.
In particular, kidney disease can arise from the use of chemotherapeutic agents. ...Given the link between kidney disease and cancer development and treatment, the aim of this Review is to highlight the importance of multidisciplinary collaboration between on …
In particular, kidney disease can arise from the use of chemotherapeutic agents. ...Given the link between kidney disea …
KCTD5 regulates Ikaros degradation induced by chemotherapeutic drug etoposide in hematological cells.
Ma L, Yin C, Zhang Y, Li J, Shi L, Zhou T, Huang X, Liu Y, Cao J, Wu G, Gu H, He L. Ma L, et al. Biol Chem. 2024 Mar 1;405(5):341-349. doi: 10.1515/hsz-2023-0333. Print 2024 May 27. Biol Chem. 2024. PMID: 38424700
In the absence of Ikaros, lymphoid cell differentiation is blocked at an extremely early stage, and myeloid cell differentiation is also significantly affected. In this work, we showed that chemotherapeutic drug etoposide reduced the protein levels of several isofor …
In the absence of Ikaros, lymphoid cell differentiation is blocked at an extremely early stage, and myeloid cell differentiation is also sig …
Chemotherapy-induced neuropathies-a growing problem for patients and health care providers.
Banach M, Juranek JK, Zygulska AL. Banach M, et al. Brain Behav. 2016 Oct 26;7(1):e00558. doi: 10.1002/brb3.558. eCollection 2017 Jan. Brain Behav. 2016. PMID: 28127506 Free PMC article. Review.
INTRODUCTION: Chemotherapy-induced neuropathies are one of the most common side effects of cancer treatment, surpassing bone marrow suppression and kidney dysfunction. ...CONCLUSIONS: The use of neurotoxic chemotherapeutics should be closely monitored and if …
INTRODUCTION: Chemotherapy-induced neuropathies are one of the most common side effects of cancer treatment, surpassing bone marrow s …
Acute kidney injury in patients with cancer receiving anti-PD-1/PD-L1 antibodies: incidence, risk factors, and prognosis.
Lou Q, Gong J, Ye B, Yu R, Bu S, Li Y, Zhu B, Shao L. Lou Q, et al. Ren Fail. 2023 Dec;45(1):2238823. doi: 10.1080/0886022X.2023.2238823. Ren Fail. 2023. PMID: 37491871 Free PMC article.
Anti-PD-1/PD-L1 antibodies are widely used in anti-cancer therapy. While they have improved cancer prognoses, immune-related adverse events, which can cause acute kidney injury (AKI), cannot be ignored. ...Improving anemia and minimizing the use of diuretics, NSAIDs …
Anti-PD-1/PD-L1 antibodies are widely used in anti-cancer therapy. While they have improved cancer prognoses, immune-related adverse …
Glomerular diseases seen with cancer and chemotherapy: a narrative review.
Jhaveri KD, Shah HH, Calderon K, Campenot ES, Radhakrishnan J. Jhaveri KD, et al. Kidney Int. 2013 Jul;84(1):34-44. doi: 10.1038/ki.2012.484. Epub 2013 Jan 30. Kidney Int. 2013. PMID: 23364518 Free article. Review.
Glomerular lesions have been recognized in a number of malignant diseases. Membranous nephropathy is the most common glomerular pathology associated with solid tumors. ...This review describes the association of glomerular diseases with solid tumors, hematological m …
Glomerular lesions have been recognized in a number of malignant diseases. Membranous nephropathy is the most common glomerular patho …
Cisplatin-induced renal salt wasting syndrome.
Hamdi T, Latta S, Jallad B, Kheir F, Alhosaini MN, Patel A. Hamdi T, et al. South Med J. 2010 Aug;103(8):793-9. doi: 10.1097/SMJ.0b013e3181e63682. South Med J. 2010. PMID: 20622742 Review.
Cisplatin was the first platinum compound to be introduced as a chemotherapeutic agent with antineoplastic activity against a wide variety of solid tumors. ...Substituting cisplatin with carboplatin depends on individual clinical settings. Prognosis is excellent, as …
Cisplatin was the first platinum compound to be introduced as a chemotherapeutic agent with antineoplastic activity against a wide va …
64 results